153 related articles for article (PubMed ID: 16498597)
61. Livedoid vasculopathy associated with plasminogen activator inhibitor-1 promoter homozygosity (4G/4G) treated successfully with tissue plasminogen activator.
Deng A; Gocke CD; Hess J; Heyman M; Paltiel M; Gaspari A
Arch Dermatol; 2006 Nov; 142(11):1466-9. PubMed ID: 17116837
[TBL] [Abstract][Full Text] [Related]
62. Metabolic predictors of inflammation, adhesion, and coagulability in healthy younger-aged adults.
Mills PJ; Shapiro D; Goldstein IB; Ottaviani C; Pung MA; Khandrika S; von Känel R; Rutledge TR
Obesity (Silver Spring); 2008 Dec; 16(12):2702-6. PubMed ID: 18820652
[TBL] [Abstract][Full Text] [Related]
63. Markedly impaired fibrinolytic balance contributes to cardiovascular risk in adults with growth hormone deficiency.
Devin JK; Blevins LS; Verity DK; Chen Q; Bloodworth JR; Covington J; Vaughan DE
J Clin Endocrinol Metab; 2007 Sep; 92(9):3633-9. PubMed ID: 17579195
[TBL] [Abstract][Full Text] [Related]
64. Sex-specific, independent associations of insulin resistance with erythrocyte sedimentation rate in apparently healthy subjects.
López-Bermejo A; Hernández-Aguado I; Vera IJ; Recasens M; Esteve E; Casamitjana R; Ricart W; Fernández-Real JM
Thromb Haemost; 2007 Feb; 97(2):240-4. PubMed ID: 17264953
[TBL] [Abstract][Full Text] [Related]
65. [PAI-1, the primary plasmatic inhibitor of fibrinolysis. Physiopathologic role and molecular mechanisms].
Banfi C; Mussoni L; Tremoli E
Minerva Endocrinol; 2002 Sep; 27(3):181-91. PubMed ID: 12091793
[TBL] [Abstract][Full Text] [Related]
66. Hypofibrinolysis and insulin-resistance.
Juhan-Vague I; Vague P
Diabete Metab; 1991 May; 17(1 Pt 2):96-100. PubMed ID: 1936490
[TBL] [Abstract][Full Text] [Related]
67. [Alterations of fibrinolysis in stroke].
Hernández Nuñez A; Romero Barbero JL; Cáceres Sansaloni A; Pérez de Oteyza C
An Med Interna; 1996 Mar; 13(3):107-10. PubMed ID: 8679836
[TBL] [Abstract][Full Text] [Related]
68. Additive effect of interleukin-6 and C-reactive protein (CRP) single nucleotide polymorphism on serum CRP concentration and other cardiovascular risk factors.
Paik JK; Kim OY; Koh SJ; Jang Y; Chae JS; Kim JY; Kim HJ; Hyun YJ; Cho JR; Lee JH
Clin Chim Acta; 2007 May; 380(1-2):68-74. PubMed ID: 17335789
[TBL] [Abstract][Full Text] [Related]
69. Novel distribution pattern of fibrinolytic components in rabbit tissues extract: a preliminary study.
Lu XG; Wu XG; Xu XH; Gong XB; Zhou X; Xu GB; Zhu L; Zhao XY
J Zhejiang Univ Sci B; 2007 Aug; 8(8):570-4. PubMed ID: 17657859
[TBL] [Abstract][Full Text] [Related]
70. Correlation between plasminogen activator inhibitor-1 4G/5G polymorphism and pre-eclampsia: an appraisal.
Wiwanitkit V
Arch Gynecol Obstet; 2006 Mar; 273(6):322-4. PubMed ID: 16502012
[TBL] [Abstract][Full Text] [Related]
71. Epistatic effect of plasminogen activator inhibitor 1 and beta-fibrinogen genes on risk of glomerular microthrombosis in lupus nephritis: interaction with environmental/clinical factors.
Gong R; Liu Z; Li L
Arthritis Rheum; 2007 May; 56(5):1608-17. PubMed ID: 17469143
[TBL] [Abstract][Full Text] [Related]
72. Fibrin D-dimer, tissue plasminogen activator, plasminogen activator inhibitor, and the risk of major ischaemic heart disease in the Caerphilly Study.
Lowe GD; Yarnell JW; Sweetnam PM; Rumley A; Thomas HF; Elwood PC
Thromb Haemost; 1998 Jan; 79(1):129-33. PubMed ID: 9459337
[TBL] [Abstract][Full Text] [Related]
73. Prognostic value of plasma fibrinolysis activation markers in cardiovascular disease.
Gorog DA
J Am Coll Cardiol; 2010 Jun; 55(24):2701-9. PubMed ID: 20538163
[TBL] [Abstract][Full Text] [Related]
74. Coagulation and fibrinolytic responses to manual versus automated snow removal.
Womack CJ; Paton CM; Coughlin AM; Nagelkirk P; Dejong AT; Anderson J; Franklin BA
Med Sci Sports Exerc; 2003 Oct; 35(10):1755-9. PubMed ID: 14523316
[TBL] [Abstract][Full Text] [Related]
75. Relation of hormone-replacement therapy to measures of plasma fibrinolytic activity. Atherosclerosis Risk in Communities (ARIC) Study Investigators.
Shahar E; Folsom AR; Salomaa VV; Stinson VL; McGovern PG; Shimakawa T; Chambless LE; Wu KK
Circulation; 1996 Jun; 93(11):1970-5. PubMed ID: 8640970
[TBL] [Abstract][Full Text] [Related]
76. The complex between tPA and PAI-1: risk factor for myocardial infarction as studied in the SHEEP project.
Nordenhem A; Leander K; Hallqvist J; de Faire U; Sten-Linder M; Wiman B
Thromb Res; 2005; 116(3):223-32. PubMed ID: 15935831
[TBL] [Abstract][Full Text] [Related]
77. Perioperative Factors and Their Effect on the Fibrinolytic System in Arthroplasty Patients.
Burleson A; Guler N; Banos A; Syed D; Wanderling C; Hoppensteadt D; Rees H; Fareed J; Hopkinson W
Clin Appl Thromb Hemost; 2016 Apr; 22(3):274-9. PubMed ID: 26460335
[TBL] [Abstract][Full Text] [Related]
78. Insulin resistance syndrome and fibrinolytic activity: the northern Sweden MONICA study.
Lindahl B; Asplund K; Eliasson M; Evrin P-E
Int J Epidemiol; 1996 Apr; 25(2):291-9. PubMed ID: 9119554
[TBL] [Abstract][Full Text] [Related]
79. Determinants of tPA antigen and associations with coronary artery disease and acute cerebrovascular disease.
Carter AM; Catto AJ; Grant PJ
Thromb Haemost; 1998 Oct; 80(4):632-6. PubMed ID: 9798983
[TBL] [Abstract][Full Text] [Related]
80. Inheritance conjointly contributing to fibrinolysis and hyperlipidemia.
Glueck CJ; Glueck HI; Tracy T; Speirs J; Stroop D
Metabolism; 1993 Nov; 42(11):1410-9. PubMed ID: 8231835
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
